X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31239) 31239
Publication (2267) 2267
Newsletter (1038) 1038
Newspaper Article (645) 645
Book Review (593) 593
Book Chapter (224) 224
Magazine Article (141) 141
Conference Proceeding (81) 81
Book / eBook (74) 74
Dissertation (40) 40
Trade Publication Article (22) 22
Web Resource (7) 7
Report (6) 6
Data Set (5) 5
Presentation (3) 3
Reference (3) 3
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteoporosis (26331) 26331
humans (21642) 21642
female (18846) 18846
endocrinology & metabolism (13784) 13784
index medicus (12920) 12920
middle aged (11589) 11589
aged (10502) 10502
postmenopausal women (9949) 9949
bone density (8877) 8877
male (8233) 8233
fractures (6873) 6873
bones (6285) 6285
orthopedics (6051) 6051
risk factors (6040) 6040
adult (5972) 5972
density (5816) 5816
women (5778) 5778
animals (5727) 5727
bone mineral density (5472) 5472
medicine & public health (4999) 4999
bone-mineral density (4916) 4916
endocrinology (4447) 4447
mineral density (4285) 4285
aged, 80 and over (4239) 4239
bone density - drug effects (4141) 4141
research (4119) 4119
rheumatology (3883) 3883
health aspects (3768) 3768
bone density - physiology (3304) 3304
risk (3260) 3260
analysis (3176) 3176
absorptiometry, photon (3174) 3174
menopause (2944) 2944
hip fracture (2921) 2921
bone (2873) 2873
postmenopausal osteoporosis (2843) 2843
osteoporosis - drug therapy (2780) 2780
rats (2738) 2738
metabolism (2650) 2650
mass (2617) 2617
prevention (2511) 2511
bone and bones - metabolism (2498) 2498
care and treatment (2492) 2492
physiological aspects (2384) 2384
osteoporosis, postmenopausal - drug therapy (2372) 2372
estrogen (2340) 2340
calcium (2274) 2274
bone density conservation agents - therapeutic use (2267) 2267
fracture (2262) 2262
vitamin d (2240) 2240
ovariectomy (2197) 2197
hormone replacement therapy (2139) 2139
men (1984) 1984
osteoporosis - physiopathology (1980) 1980
alendronate (1903) 1903
age (1893) 1893
mice (1855) 1855
osteoporosis - etiology (1844) 1844
diagnosis (1792) 1792
osteoporosis - prevention & control (1779) 1779
drug therapy (1677) 1677
osteoporosis - metabolism (1676) 1676
cross-sectional studies (1631) 1631
bisphosphonates (1624) 1624
cell biology (1621) 1621
bone loss (1593) 1593
prevalence (1565) 1565
therapy (1543) 1543
medicine, research & experimental (1535) 1535
medicine (1529) 1529
article (1512) 1512
spine (1491) 1491
bone and bones - drug effects (1472) 1472
osteoporosis, postmenopausal - physiopathology (1469) 1469
bone turnover (1456) 1456
fracture risk (1435) 1435
biomarkers - blood (1432) 1432
osteoporosis, postmenopausal - prevention & control (1422) 1422
epidemiology (1419) 1419
gynecology (1417) 1417
vertebral fractures (1412) 1412
osteoporosis - epidemiology (1409) 1409
osteoporosis - complications (1405) 1405
prospective studies (1384) 1384
bone resorption (1383) 1383
parathyroid hormone (1367) 1367
body mass index (1362) 1362
postmenopause (1358) 1358
hip (1340) 1340
turnover (1329) 1329
femur (1318) 1318
parathyroid-hormone (1315) 1315
adolescent (1294) 1294
pharmacology & pharmacy (1292) 1292
internal medicine (1288) 1288
disease (1258) 1258
older people (1256) 1256
treatment outcome (1256) 1256
bone mass (1251) 1251
complications and side effects (1242) 1242
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (50) 50
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (7) 7
New College (Ivey) - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Providence Healthcare - Stacks (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32387) 32387
German (172) 172
Japanese (165) 165
Spanish (159) 159
French (96) 96
Chinese (93) 93
Polish (58) 58
Korean (54) 54
Russian (45) 45
Turkish (38) 38
Portuguese (31) 31
Italian (29) 29
Czech (15) 15
Danish (14) 14
Hungarian (12) 12
Dutch (7) 7
Norwegian (6) 6
Swedish (6) 6
Croatian (5) 5
Finnish (4) 4
Serbian (4) 4
Bulgarian (3) 3
Romanian (3) 3
Slovak (3) 3
Malay (2) 2
Arabic (1) 1
Hebrew (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Calcified Tissue International, ISSN 0171-967X, 4/2012, Volume 90, Issue 4, pp. 251 - 262
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 09/2017, Volume 106, Issue 3, pp. 909 - 920
Background: Female age-related estrogen deficiency increases the risk of osteoporosis, which can be effectively treated with the use of hormone replacement... 
Isoflavone | Probiotics | Equol | Postmenopause | Bone density | Bioavailability | Bone turnover | Osteopenia | osteopenia | equol | bone density | PREVENTION | RISK | FORMONONETIN | bone turnover | OVARIAN-CANCER | HORMONE REPLACEMENT THERAPY | PHYTOESTROGENS | OSTEOPOROSIS | RED-CLOVER | isoflavone | MINERAL DENSITY | NUTRITION & DIETETICS | bioavailability | SOY ISOFLAVONES | postmenopause | probiotics | Collagen Type I - blood | Intestines - drug effects | Peptides - blood | Estrogens - deficiency | Plant Extracts - pharmacology | Humans | Isoflavones - pharmacology | Middle Aged | Osteoporosis, Postmenopausal - metabolism | Biological Availability | Intestines - metabolism | Bone Remodeling - drug effects | Bone and Bones - drug effects | Trifolium - chemistry | Bone Diseases, Metabolic - drug therapy | Selective Estrogen Receptor Modulators - therapeutic use | Bone and Bones - metabolism | Female | Phytotherapy | Estrogens - metabolism | Osteoporosis, Postmenopausal - prevention & control | Isoflavones - blood | Double-Blind Method | Isoflavones - pharmacokinetics | Gastrointestinal Microbiome | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - pharmacology | Bone Diseases, Metabolic - metabolism | Bone Density - drug effects | Intestines - microbiology | Probiotics - therapeutic use | Isoflavones - therapeutic use | Plant Extracts - therapeutic use | Selective Estrogen Receptor Modulators - pharmacology | Drug Combinations | Diet therapy | Red clover | Nutritional aspects | Postmenopausal women | Food and nutrition | Health aspects | Isoflavones | Materia medica, Vegetable | Plant extracts | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2012, Volume 27, Issue 11, pp. 2259 - 2263
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1276 - 1287
Summary Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that results in fragility fractures. With an... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SCLEROSTIN ANTIBODY | BONE-MINERAL DENSITY | CALCIUM-SENSING RECEPTOR | HUMAN OSTEOBLASTIC CELLS | OSTEOPROTEGERIN LIGAND | CATHEPSIN-K INHIBITOR | STRONTIUM RANELATE | VERTEBRAL FRACTURE | HEALTHY POSTMENOPAUSAL WOMEN | FRACTURE RISK | Wnt Proteins - drug effects | Vitamin D Deficiency - complications | Calcium - metabolism | Bone Morphogenetic Proteins - immunology | Humans | Middle Aged | Osteoporosis - diagnosis | Osteoporosis, Postmenopausal - metabolism | Antibodies, Monoclonal - therapeutic use | Osteoporosis - drug therapy | Wnt Proteins - metabolism | Biphenyl Compounds - therapeutic use | Osteoporosis - etiology | Bone Remodeling - drug effects | Antibodies, Monoclonal, Humanized | Osteoporosis - metabolism | Vitamin D Deficiency - therapy | Aged, 80 and over | Bone Resorption - metabolism | Diphosphonates - therapeutic use | Female | Benzodioxoles - therapeutic use | RANK Ligand - therapeutic use | Anabolic Agents - therapeutic use | Osteoporosis - prevention & control | Risk Assessment | Osteoporotic Fractures - prevention & control | Risk Factors | Bone Resorption - drug therapy | Bone Density Conservation Agents - therapeutic use | Denosumab | Absorptiometry, Photon | Genetic Markers - immunology | Osteoclasts - metabolism | Osteoporosis, Postmenopausal - drug therapy | Randomized Controlled Trials as Topic | Bone Density - drug effects | Quinazolines - therapeutic use | Aged | Osteoblasts - metabolism | Intercellular Signaling Peptides and Proteins - immunology | Osteoporosis | Complications and side effects | Care and treatment | Diagnosis | Bones | Vitamin D | Womens health | Metabolic disorders | Cathepsin K | Cytokines | Proteinase | Socio-economic aspects | SOST protein | Osteoblasts | Post-menopause | Bone resorption | NF- Kappa B protein | Bone mass | Fractures | Reviews | Aging | Monoclonal antibodies | Osteoclasts | Dkk1 protein | Osteogenesis | Communication
Journal Article
Osteoporosis International, ISSN 0937-941X, 2/2011, Volume 22, Issue 2, pp. 391 - 420
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2013, Volume 110, Issue 41, pp. 16568 - 16573
Journal Article
Journal Article